MUC1, a high molecular weight glycoprotein, has been identified as a potential biomarker for RCC, which including cellular proliferation, metabolic reprogramming, and angiogenesis—processes that are essential for the progression of RCC (48). The gene discussed is MUC1; the disease is renal cell carcinoma.